Bausch Health director receives RSU share grant

Bausch Health Companies Inc. director Amy B. Wechsler received an equity-based compensation grant rather than cash for her board service for the quarter ending June 30, 2026.

Rhea-AI Filing Summary

Bausch Health Companies Inc. director Amy B. Wechsler received an equity-based compensation grant rather than cash for her board service for the quarter ending June 30, 2026. She was awarded 1,394 Restricted Share Units, each representing a contingent right to receive one common share.

The grant is recorded at a reference price of $4.93 per share and is classified as a non-derivative acquisition. Following this award, Wechsler’s direct holdings increased to 314,979 common shares, reinforcing that this is a routine compensation-related transaction rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 1,394 shares

Grant/Award 1 txn

Insider WECHSLER AMY B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	1,394	$4.93	$7K

Holdings After Transaction: Common Shares, No Par Value — 314,979 shares (Direct)

Footnotes (1)

1. F1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

Key Figures

RSUs granted: 1,394 units Grant price: $4.93 per share Shares owned after transaction: 314,979 shares +1 more

4 metrics

RSUs granted 1,394 units Restricted Share Units issued in lieu of cash fees for quarter ending June 30, 2026

Grant price $4.93 per share Reference price for RSU grant on common shares, no par value

Shares owned after transaction 314,979 shares Direct common share holdings following RSU grant to director

Transaction date June 30, 2026 Date of RSU grant tied to quarter-end board compensation

Key Terms

Restricted Share Units, in lieu of cash compensation, contingent right, Board of Directors

4 terms

Restricted Share Units financial

"Reflects Restricted Share Units issued in lieu of cash compensation"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

in lieu of cash compensation financial

"issued in lieu of cash compensation in connection with the Reporting Person's service"

contingent right financial

"each representing a contingent right to receive one common share"

Board of Directors financial

"in connection with the Reporting Person's service on the Issuer's Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bausch Health (BHC) director Amy Wechsler report?

Amy Wechsler reported receiving 1,394 Restricted Share Units as compensation. These equity awards replace cash fees for her board service for the quarter ending June 30, 2026, and each RSU represents a contingent right to one Bausch Health common share.

Was the Bausch Health (BHC) Form 4 transaction an open-market stock purchase?

No, the transaction was not an open-market purchase. The Form 4 shows a compensation-related grant of 1,394 Restricted Share Units issued in lieu of cash for board service, rather than shares bought or sold in the market at the insider’s discretion.

How many Bausch Health (BHC) shares does Amy Wechsler hold after this Form 4?

After the reported grant, Amy Wechsler directly holds 314,979 Bausch Health common shares. This figure reflects her position following the issuance of 1,394 Restricted Share Units in lieu of cash compensation for the quarter ending June 30, 2026.

What does each Restricted Share Unit in the Bausch Health (BHC) filing represent?

Each Restricted Share Unit represents a contingent right to receive one Bausch Health common share. These RSUs were issued instead of cash compensation for Amy Wechsler’s board service for the quarter ending June 30, 2026, aligning her compensation more closely with shareholder interests.

What price per share is associated with Amy Wechsler’s Bausch Health (BHC) RSU grant?

The RSU grant is recorded at $4.93 per share. This price is used as the reference value for the 1,394 Restricted Share Units awarded as non-cash compensation for her service on Bausch Health’s Board of Directors for the quarter ending June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WECHSLER AMY B

(Last) (First) (Middle)

400 SOMERSET CORPORATE BOULEVARD

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	06/30/2026		A		1,394(1)	A	$4.93	314,979	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)